efavirenz and Chemical Dependence

efavirenz has been researched along with Chemical Dependence in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's5 (45.45)29.6817
2010's5 (45.45)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fourie, J; Harvey, BH; Möller, M1
Althoff, KN; Brown, TT; Erlandson, KM; Jacobson, LP; Kingsley, LA; Lake, JE; Margolick, JB; Ng, DK; Palella, FJ; Zhang, L1
Essop, MR; Meel, R; Peters, F1
Bednasz, C; DiFrancesco, R; Feng, Z; Fischl, MA; Gripshover, BM; Gu, J; Luque, AE; Ma, Q; Morse, GD; Venuto, CS; Zingman, BS1
Blank, A; Burhenne, J; Haefeli, WE; Hartmann, M; Hellstern, V; Matthée, AK; Mikus, G; Schuster, D1
DiFrancesco, R; Fischl, MA; Forrest, A; Gripshover, BM; Luque, AE; Ma, Q; Morse, GD; Venuto, CS; Zingman, BS1
Antolini, D; Concia, E; Faggian, F; Lanzafame, M; Lattuada, E; Vento, S1
Preisig, M; Saraga, M; Zullino, DF1
DiFrancesco, R; Donnelly, J; Fischl, MA; Gripshover, B; McCance-Katz, EF; Moody, DE; Morse, GD; Reichman, RC; Zingman, BS1
Fornataro, K1
Clarke, SM; Mulcahy, FM1

Reviews

1 review(s) available for efavirenz and Chemical Dependence

ArticleYear
Efavirenz therapy in drug users.
    HIV medicine, 2000, Volume: 1 Suppl 1

    Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Methadone; Oxazines; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous; Substance-Related Disorders

2000

Trials

1 trial(s) available for efavirenz and Chemical Dependence

ArticleYear
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:3

    Topics: Alkynes; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Monitoring; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; RNA, Viral; Substance-Related Disorders

2011

Other Studies

9 other study(ies) available for efavirenz and Chemical Dependence

ArticleYear
Efavirenz exposure, alone and in combination with known drugs of abuse, engenders addictive-like bio-behavioural changes in rats.
    Scientific reports, 2018, 08-27, Volume: 8, Issue:1

    Topics: Alkynes; Animals; Behavior, Addictive; Behavior, Animal; Benzoxazines; Biomarkers; Body Weight; Brain; Cyclopropanes; Disease Models, Animal; Illicit Drugs; Lipid Metabolism; Male; Rats; Substance-Related Disorders

2018
Risk Factors for Falls, Falls With Injury, and Falls With Fracture Among Older Men With or at Risk of HIV Infection.
    Journal of acquired immune deficiency syndromes (1999), 2019, 08-01, Volume: 81, Issue:4

    Topics: Accidental Falls; Aged; Alkynes; Benzoxazines; Cohort Studies; Cyclopropanes; Exercise; Female; Fractures, Bone; HIV Infections; Humans; Logistic Models; Male; Middle Aged; Risk Factors; Substance-Related Disorders

2019
Tricuspid valve endocarditis associated with intravenous nyoape use: a report of 3 cases.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2014, Volume: 104, Issue:12

    Topics: Adult; Alkynes; Anti-Bacterial Agents; Benzoxazines; Cannabis; Cyclopropanes; Endocarditis; Heroin; HIV Infections; Humans; Illicit Drugs; Male; Methamphetamine; Pulmonary Embolism; Ritonavir; South Africa; Substance-Related Disorders; Tricuspid Valve; Tricuspid Valve Insufficiency; Young Adult

2014
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.
    Current vascular pharmacology, 2016, Volume: 14, Issue:3

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Dyslipidemias; Female; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Lipodystrophy; Male; Middle Aged; Retrospective Studies; Substance-Related Disorders

2016
Efavirenz treatment and false-positive results in benzodiazepine screening tests.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jun-15, Volume: 48, Issue:12

    Topics: Alkynes; Anti-HIV Agents; Benzodiazepines; Benzoxazines; Cyclopropanes; False Positive Reactions; HIV Infections; Humans; Substance Abuse Detection; Substance-Related Disorders; Urine

2009
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients.
    AIDS care, 2005, Volume: 17, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Oxazines; Retrospective Studies; Substance-Related Disorders

2005
Reduced valproate plasma levels possible after introduction of efavirenz in a bipolar patient.
    Bipolar disorders, 2006, Volume: 8, Issue:4

    Topics: Adult; Alkynes; Anti-HIV Agents; Anticonvulsants; Benzoxazines; Bipolar Disorder; Cyclopropanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Male; Oxazines; Substance-Related Disorders; Valproic Acid

2006
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
    Journal of pharmaceutical and biomedical analysis, 2007, May-09, Volume: 44, Issue:1

    Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Biological Assay; Buprenorphine; Calibration; Chromatography, Liquid; Cyclopropanes; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Mass Spectrometry; Molecular Structure; Narcotic Antagonists; Oligopeptides; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Substance-Related Disorders; Tandem Mass Spectrometry

2007
Methadone and anti-HIV drugs.
    The Body positive, 1999, Volume: 12, Issue:5

    Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Infections; Humans; Methadone; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Substance-Related Disorders

1999